CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection

American Journal of Pathology

Volumn 158, Issue 5, 2001, Pages 1703-1711

  Agostini, Carlo ^a   Calabrese, Fiorella ^a   Rea, Federico ^a   Facco, Monica ^a   Tosoni, Alicia ^a   Loy, Monica ^a   Binotto, Gianni ^a   Valente, Marialuisa ^a   Trentin, Livio ^a   Semenzato, Gianpietro ^a,b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCL10; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; UNCLASSIFIED DRUG;

ARTICLE; CELL SECRETION; CHEMOTAXIS; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; LUNG ALVEOLUS MACROPHAGE; LUNG BIOPSY; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0035024450     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64126-0     Document Type: Article

References (39)

1. Lung transplantation
2. Lung transplantation
3. Bronchiolitis obliterans syndrome: Incidence, natural history, prognosis, and risk factors
4. Obliterative bronchiolitis
5. T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas
6. Chemotactic cytokines: From the molecular level to clinical use
7. Chemokines: Signal lamps for trafficking of T and B cells for development and effector function
8. Chemokines and leukocyte traffic
9. Chemokines-chemotactic cytokines that mediate inflammation
10. Recent advances in chemokines and chemokine receptors
11. Mig and IP-10: CXC chemokines that target lymphocytes
12. Chemokine receptor specific for IP-10 and Mig: Structure, function and expression in activated T-lymphocytes
13. International union of pharmacology. XXII. Nomenclature for chemokine receptors
14. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung rejection study group
15. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European society of pneumology task group on BAL
16. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions
17. Bronchoalveolar lavage in lung transplantation. State of the art
18. Risk factors for the development of obliterative bronchiolitis after lung transplantation
19. Endobronchial biopsy and bronchoalveolar lavage in stable lung transplant recipients and chronic rejection
20. CXC chemokines IP-10 and Mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T-cell alveolitis
21. Upregulation of T-helper 1 cytokines and chemokine expression in post-transplant airway obliteration
22. Enhanced T cell cytokine gene expression in mouse airway obliterative bronchiolitis
23. Expression of gamma-IFN mRNA in bronchoalveolar lavage fluid correlates with early acute allograft rejection in lung transplant recipients
24. IL-15 induces the expression of chemokines and their receptors in T lymphocytes
25. Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process
26. Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFN-gamma over IL-4 responses
27. CXC chemokines in angiogenesis
28. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: Role of IL-8
29. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis
30. Immune effector cells in idiopathic pulmonary fibrosis
31. NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease
32. The role of the CC chemokine, RANTES, in acute lung allograft rejection
33. Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantation
34. Eosinophilic alveolitis in BAL after lung transplantation
35. Persistent increases of BAL neutrophils as a predictor of mortality following lung transplant
36. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation
37. The potential role of mast cells in lung allograft rejection
38. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts
39. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells